These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8658840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, Dickson RC, Caldwell SH, Pruett TL.
    Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation.
    Zöllner B, Polywka S, Feucht HH, Martens H, Iske L, Oehler G, Laufs R.
    Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.
    Caccamo L, Belli LS, Mazzaferro V, Colledan M, Alberti A, Regalia E, Fassati LR, Ideo G, Rubino A, Belli L.
    Transplant Proc; 1994 Dec; 26(6):3585-7. PubMed ID: 7998283
    [No Abstract] [Full Text] [Related]

  • 9. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF, Herrero JI.
    An Sist Sanit Navar; 2004 Apr; 27 Suppl 2():91-101. PubMed ID: 15381947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J, Crafa F, Fabiani P, Goubaux B, Ouzan D, Mouiel J.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract] [Full Text] [Related]

  • 18. [Development of cirrhosis after chronic hepatitis B].
    Hazama H, Koga M.
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():354-7. PubMed ID: 15453345
    [No Abstract] [Full Text] [Related]

  • 19. [Mutants of the pre-c region of the hepatitis B virus associated with severe recurrence after liver transplantation].
    Féray C.
    Gastroenterol Clin Biol; 1995 Nov; 19(11):964-5. PubMed ID: 8746067
    [No Abstract] [Full Text] [Related]

  • 20. HBV prophylaxis: cost/benefit analysis following liver transplantation for HBV-positive liver cirrhosis.
    Golling M, Arnold JC, Rudek B, Mehrabi A, Kraus T, Herfarth C, Klar E.
    Transplant Proc; 1998 Nov; 30(7):3316-7. PubMed ID: 9838466
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.